Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - atorvastatin calcium propylene glycol solvate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - atorvastatin calcium propylene glycol solvate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - atorvastatin calcium propylene glycol solvate -

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - isavuconazonium sulfate, quantity: 186.3 mg (equivalent: isavuconazole, qty 100 mg) - capsule - excipient ingredients: potassium acetate; gellan gum; iron oxide red; sodium lauryl sulfate; titanium dioxide; hypromellose; disodium edetate; magnesium citrate; microcrystalline cellulose; purified talc; colloidal anhydrous silica; stearic acid; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - cresemba is indicated in adults for the treatment of ? invasive aspergillosis ? mucormycosis in patients for whom amphotericin b is inappropriate (see section 4.4 special warnings and precautions for use and section 5.1 pharmacodynamic properties),consideration should be given to official guidance on the appropriate use of antifungal agents.

Israel - English - Ministry of Health

trupharm marketing 1985 ltd. - aluminium chloride hexahydrate - solution - aluminium chloride hexahydrate 20 %w/v - aluminium chlorohydrate - aluminium chlorohydrate - for the topical treatment of hyperhydrosis specifically involving axillae, hands or feet.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius medical care nephrologica deutschland gmbh - calcium acetate - film coated tablet - 660 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius medical care nephrologica deutschland gmbh - calcium acetate magnesium carbonate heavy - film coated tablet - 435 / 235 milligram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vifor fresenius medical care renal pharma uk ltd - calcium acetate; magnesium carbonate heavy - oral tablet - 435mg ; 235mg

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - aspirin,clopidogrel hydrogen sulfate -